Related Experiment Video
Updated: Sep 4, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Mortality among patients treated for aneurysmal subarachnoid hemorrhage in Eastern Denmark 2017-2019
Agnes T Stauning1, Frank Eriksson2, Goetz Benndorf3,4
1Department of Neurosurgery, Copenhagen University Hospital, Inge Lehmanns Vej 6, 2100, Copenhagen, Denmark. atvings@hotmail.com.
Insights
This study found that 16.1% of patients died within 12 months of aneurysm treatment. Key risk factors for death include severe hemorrhage, infections, rebleeding, and specific patient conditions, highlighting areas for improved aneurysm occlusion strategies.
Area of Science:
- Neurosurgery
- Vascular Surgery
- Critical Care Medicine
Background:
- Subarachnoid hemorrhage (SAH) from ruptured aneurysms carries significant mortality.
- Effective aneurysm occlusion is crucial for patient survival and preventing secondary complications.
Purpose of the Study:
- To determine 30-day, 3-month, and 12-month cumulative mortality rates after aneurysm occlusion.
- To identify the primary causes of death in these patients.
- To investigate potential risk factors associated with mortality following aneurysm treatment.
Main Methods:
- A cohort study included 317 patients treated for ruptured aneurysms (surgical clipping or endovascular) between 2017-2019.
- Patients were followed for 12 months to collect data on vital status, causes of death, and comorbidities.
- Logistic regression models were used to assess associations between risk factors and mortality.
Main Results:
- Overall cumulative mortality was 10.7% at 30 days, 12.9% at 3 months, and 16.1% at 12 months.
- The leading causes of death were severe primary hemorrhage (52.9%), infections (15.7%), and rebleeding (11.8%).
- Higher WFNS and Fisher scores, preprocedural hydrocephalus, and preprocedural rebleeding were significant risk factors for death.
Conclusions:
- Aneurysm occlusion is associated with considerable mortality, with preventable causes contributing to a portion of deaths.
- Reducing time to treatment and improving occlusion techniques are essential for reducing mortality.
- Addressing pre- and postprocedural rebleeding is critical for improving patient outcomes.
Objective:
The aim of the study was to investigate (1) the 30-day, 3-month, and 12-month cumulative mortalities for patients who underwent aneurysm occlusion, and (2) the causes of death, and (3) the potential risk factors for death.
Methods:
All patients who underwent surgical clipping or endovascular treatment of a ruptured aneurysm at Copenhagen University Hospital, during the period of January 1, 2017-December 31, 2019, were included and followed up for 12 months. Data regarding vital status, causes of death, comorbidities, treatment, and clinical presentations on admission was collected. The absolute mortality risk was estimated as a function of time with a 95% confidence interval. The associations between potential risk factors and death were estimated as odds ratios with 95% confidence intervals using logistic regression models.
Results:
A total of 317 patients were included. The overall cumulative mortalities after 30 days, 3 months, and 12 months were 10.7%, 12.9%, and 16.1%, respectively. The most common cause of death was severe primary hemorrhage (52.9%), followed by infections (15.7%) and rebleeding (11.8%). WFNS score > 3 and Fisher score > 3 on admission, preprocedural hydrocephalus, and preprocedural rebleeding were found significantly associated with higher risk of death.
Conclusions:
Considerable mortality was seen. Possible preventable causes accounted for approximately 22% of the deaths. The occurrence of both pre- and postprocedural rebleeding's indicates an opportunity of further improvement of the mortality by (1) further reduction of time from aSAH to aneurysm occlusion and (2) continuous efforts in improving methods of aneurysm occlusion.
More Related Videos
Related Concept Videos
Aneurysm III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm IV: Nursing Management

